Related Experiment Videos

Immunofluorescent and histochemical staining confirm the identification of the many diseases called interstitial

L Gillespie1, J Said, S Sostrin

  • 1Women's Clinic for Interstitial Cystitis, Beverly Hills, California.

British Journal of Urology
|September 1, 1990
PubMed

Insights

Interstitial cystitis involves pelvic pain. Immunofluorescent staining identifies four distinct diseases and predicts bladder capacity loss, aiding diagnosis and patient management.

Area of Science:

  • Urology
  • Pathology
  • Immunology

Background:

  • Interstitial cystitis presents with pelvic pain, but functional symptoms don't predict anatomical changes.
  • Diagnosing interstitial cystitis and its subtypes is challenging for clinicians.

Purpose of the Study:

  • To evaluate histochemical and immunofluorescent staining for improved interstitial cystitis diagnosis.
  • To identify distinct disease entities within interstitial cystitis based on urothelial and endothelial responses to injury.
  • To determine sensitive predictors for age-related loss of bladder capacity in interstitial cystitis patients.

Main Methods:

  • Histochemical staining using PAS-colloidal iron/Van Geison's counterstain.
  • Immunofluorescent staining to identify distinct disease patterns.
  • Correlation of staining results with clinical findings of pelvic pain and bladder capacity.

Main Results:

  • Histochemical staining enhances diagnostic accuracy for pathologists.
  • Immunofluorescent staining revealed four distinct interstitial cystitis diseases.
  • IgM deposition in interstitial capillaries is a sensitive predictor of reduced bladder capacity, independent of age.

Conclusions:

  • Immunofluorescent staining differentiates interstitial cystitis subtypes based on injury response.
  • IgM capillary staining is a superior predictor of bladder capacity loss compared to age.
  • Advanced staining techniques improve diagnosis and understanding of interstitial cystitis pathogenesis.

Related Concept Videos